MedPath
HSA Approval

FENADIUM TABLETS 25 mg

SIN05568P

FENADIUM TABLETS 25 mg

FENADIUM TABLETS 25 mg

March 7, 1991

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

ENTERIC COATED TABLET

ORAL

Medical Information

M01AB05

diclofenac

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL SDN BHD

Active Ingredients

DICLOFENAC SODIUM

25 mg

Diclofenac

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FENADIUM TABLETS 25 mg - HSA Approval | MedPath